Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

about

Modulating P2X7 Receptor Signaling during Rheumatoid Arthritis: New Therapeutic Approaches for Bisphosphonates

P2860

Q36101996-0D65CE62-4217-49D7-AC3B-D90EA7AFBD2B

P2860

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

Item

http://www.wikidata.org/entity/Q35683994

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

@ast

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

@en

type

Item

label

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

@ast

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

@en

prefLabel

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

@ast

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

@en

P1476

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

@en

P2093

Mahmud Mahamid

http://www.w3.org/2001/XMLSchema#string

Reuven Mader

http://www.w3.org/2001/XMLSchema#string

Rifaat Safadi

http://www.w3.org/2001/XMLSchema#string

P2860

Anakinra for rheumatoid arthritis

Safety of extended treatment with anakinra in patients with rheumatoid arthritis

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.

What are the risks of biologic therapy in rheumatoid arthritis? An update on safety.

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk.

The role of IL-10 in crossregulation of TH1 and TH2 responses.

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis.

Liver failure after major hepatic resection.

Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.

P304

39-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2147/CPAA.S24004

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221789430

http://www.w3.org/2001/XMLSchema#string

P698

22287855

http://www.w3.org/2001/XMLSchema#string

P921

hepatotoxicity

P932

3262392

http://www.w3.org/2001/XMLSchema#string

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

about

P2860

P2860

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P921

P932